Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma.
Shenouda G, Souhami L, Petrecca K, Owen S, Panet-Raymond V, Guiot MC, Corredor AG, Abdulkarim B. Shenouda G, et al. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):487-494. doi: 10.1016/j.ijrobp.2016.11.006. Epub 2016 Nov 15. Int J Radiat Oncol Biol Phys. 2017. PMID: 28011051 Clinical Trial.
Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G. Panet-Raymond V, et al. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):473-8. doi: 10.1016/j.ijrobp.2008.04.030. Epub 2008 Jun 12. Int J Radiat Oncol Biol Phys. 2009. PMID: 18554821
Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.
Bauman G, Yartsev S, Roberge D, MacRae R, Roa W, Panet-Raymond V, Masucci L, Yaremko B, D'Souza D, Palma D, Sexton T, Yu E, Pantarotto JR, Ahmad B, Fisher B, Dar AR, Lambert C, Pond G, Stitt L, Tay KY, Rodrigues G. Bauman G, et al. J Neurooncol. 2016 Jul;128(3):431-6. doi: 10.1007/s11060-016-2128-7. Epub 2016 Apr 15. J Neurooncol. 2016. PMID: 27084705 Clinical Trial.
Prognostic factors for progression in atypical meningioma.
Shakir SI, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-Odaini AA, Abdulkarim B, Guiot MC. Shakir SI, et al. J Neurosurg. 2018 Nov 1;129(5):1240-1248. doi: 10.3171/2017.6.JNS17120. Epub 2018 Jan 19. J Neurosurg. 2018. PMID: 29350599
40 results